Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CHIC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THRSP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EVI5L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RABEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX29P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC643733 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HECW1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPRD1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on